Uxin Ltd: Form 20-F for the period ended Mar 31, 2023
Filed with the SEC on Aug 14, 2023 and accepted by EDGAR at Aug 14, 2023, 16:23 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2022-04-01 to 2023-03-31 | $299.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2022-04-01 to 2023-03-31 | $296.1m | us-gaap:CostOfRevenue |
| Gross profit | 12 months2022-04-01 to 2023-03-31 | $3.7m | us-gaap:GrossProfit |
| Research and development | 12 months2022-04-01 to 2023-03-31 | $5.5m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2022-04-01 to 2023-03-31 | −$52.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2022-04-01 to 2023-03-31 | $3.1m | us-gaap:InterestExpense |
| Income tax | 12 months2022-04-01 to 2023-03-31 | $53.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2022-04-01 to 2023-03-31 | −$20.0m | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 12 months2022-04-01 to 2023-03-31 | 1,344,536,565 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2022-04-01 to 2023-03-31 | −$36.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2022-04-01 to 2023-03-31 | $4.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2023-03-31 | $13.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-03-31 | $41.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-03-31 | $104.6m | us-gaap:Assets |
| Current liabilities | At period end2023-03-31 | $87.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-03-31 | $188.8m | us-gaap:Liabilities |
| Long-term debt | At period end2023-03-31 | $42.5m | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2023-03-31 | $2.9m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2023-03-31 | −$185.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-23-042446. Last ingested by Listed: Nov 3, 2026, 09:26 ET. Listed shows no prices and gives no investment advice.